Lupus and hair loss are closely linked, with hair shedding or thinning affecting a significant proportion of people living with this chronic autoimmune condition. Whether caused by direct immune-mediated damage to hair follicles, systemic inflammation during a flare, or certain medicines used to manage the disease, hair loss in lupus can range from temporary and reversible to permanent and scarring. Understanding the different types, their causes, and the treatment options available on the NHS is essential for protecting hair health and seeking timely medical care.
Summary: Lupus causes hair loss through immune-mediated inflammation that damages hair follicles, disrupts the hair growth cycle, and — in discoid lupus — can lead to permanent scarring alopecia if not treated promptly.
- Systemic lupus erythematosus (SLE) triggers hair loss via autoantibody-driven inflammation that pushes follicles prematurely into the resting (telogen) phase.
- Discoid lupus erythematosus (DLE) causes scarring (cicatricial) alopecia through chronic interface dermatitis, resulting in irreversible follicle destruction if untreated.
- Non-scarring hair loss — including telogen effluvium and 'lupus hair fringe' — is often reversible once underlying disease activity is controlled.
- Hydroxychloroquine is the cornerstone first-line treatment for lupus-related hair loss; cyclophosphamide and methotrexate are recognised causes of hair thinning.
- Scalp biopsy is the key diagnostic tool when scarring alopecia is suspected; prompt referral to dermatology is recommended to prevent irreversible damage.
- UV light is a recognised trigger for lupus flares and cutaneous scalp disease; SPF 50+ sunscreen and protective hats are strongly advised.
Table of Contents
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
How Lupus Causes Hair Loss
Lupus causes hair loss through immune-mediated inflammation that damages hair follicles and disrupts the growth cycle; discoid lupus can cause permanent scarring, while systemic flares trigger diffuse telogen effluvium.
Not sure if this is normal? Chat with one of our pharmacists →
Lupus is a chronic autoimmune condition in which the immune system mistakenly attacks healthy tissue throughout the body, including the skin and hair follicles. In systemic lupus erythematosus (SLE), the most common form of the disease, circulating autoantibodies and inflammatory mediators can directly damage the structures responsible for hair growth. This immune-mediated inflammation disrupts the normal hair growth cycle, pushing follicles prematurely into the resting (telogen) phase and ultimately causing shedding.
The scalp skin itself may also become inflamed as part of cutaneous lupus. In discoid lupus erythematosus (DLE), a pattern of chronic inflammation known as interface dermatitis causes progressive destruction of hair follicles, which can lead to permanent scarring if not treated promptly. In some cases, the inflammation is severe enough to cause irreversible follicle loss and prevent regrowth. Beyond direct follicular damage, systemic inflammation associated with lupus flares can trigger a broader, stress-related hair loss response known as telogen effluvium, where large numbers of hairs shed simultaneously across the scalp.
Certain medicines used to manage lupus may also contribute to hair thinning as a side effect. Cyclophosphamide — used in severe, organ-threatening SLE — is a well-recognised cause of significant hair loss. Methotrexate can also contribute to hair thinning in some people. By contrast, hydroxychloroquine and corticosteroids rarely cause alopecia and often help reduce the underlying inflammation driving hair loss. Mycophenolate mofetil and azathioprine are less commonly associated with hair loss. It is important not to stop any prescribed medicine without first consulting a healthcare professional. If you suspect a medicine is causing or worsening hair loss, this can be reported to the MHRA via the Yellow Card scheme (yellowcard.mhra.gov.uk).
| Type of Hair Loss | Associated Condition | Scarring? | Typical Pattern | Reversible? | Primary Treatment |
|---|---|---|---|---|---|
| Telogen effluvium | SLE flare, systemic inflammation | No | Diffuse shedding across whole scalp | Yes, once disease controlled | Control underlying lupus activity; hydroxychloroquine |
| Lupus hair (frontal fringe) | SLE | No | Fragile, broken hairs along frontal hairline | Yes | Hydroxychloroquine; gentle hair care |
| Scarring (cicatricial) alopecia | Discoid lupus erythematosus (DLE) | Yes | Smooth, atrophic or hyperpigmented scalp patches | No — follicle loss permanent | Hydroxychloroquine; topical/intralesional corticosteroids; urgent dermatology referral |
| Alopecia areata | Co-existing autoimmune condition | No | Patchy, well-defined areas of hair loss | Often yes | Specialist dermatology assessment; separate management pathway |
| Drug-induced hair loss | Cyclophosphamide, methotrexate use | No | Diffuse thinning or shedding | Often yes, after dose review | Review medication with specialist; do not stop without medical advice |
| Androgenetic alopecia | Concurrent, independent of lupus | No | Patterned thinning at crown or temples | Partial | Topical minoxidil (UK-licensed for this indication) |
| Tinea capitis | Fungal infection, concurrent or independent | Rarely | Scaly, inflamed patches; broken hairs | Yes, with antifungal treatment | Fungal scraping to confirm; oral antifungal therapy |
Types of Hair Loss Associated with Lupus
Lupus-related hair loss includes reversible non-scarring types (telogen effluvium, lupus hair fringe) and irreversible scarring alopecia most commonly caused by discoid lupus erythematosus (DLE).
Hair loss in lupus is not a single, uniform condition — it presents in several distinct patterns, each with different implications for treatment and prognosis.
Non-scarring hair loss is the most common type and is often reversible. This includes:
-
Telogen effluvium: Diffuse shedding across the whole scalp triggered by systemic inflammation or a lupus flare. Hair typically regrows once the underlying disease is controlled.
-
Lupus hair (or 'lupus hair fringe'): A characteristic pattern of fragile, broken hairs along the frontal hairline, particularly noted in SLE. These hairs are weakened by inflammation and break easily rather than falling out at the root.
-
Alopecia areata: A separate autoimmune condition that can co-exist with lupus, causing patchy, well-defined areas of hair loss. It is not caused by lupus itself, but the two conditions may occur together.
Scarring (cicatricial) alopecia is a more serious and irreversible form, most commonly associated with discoid lupus erythematosus (DLE). In DLE, chronic interface dermatitis causes permanent destruction of hair follicles, leaving smooth, atrophic, or hyperpigmented patches on the scalp. Because follicle loss is permanent in scarring alopecia, early diagnosis and prompt treatment are essential to limit the extent of damage.
It is also worth noting that other causes of hair loss — such as androgenetic alopecia, traction alopecia from tight hairstyles, or tinea capitis (a fungal scalp infection, particularly where scaling is present) — can occur alongside or independently of lupus. A clinician will consider these differentials as part of the assessment.
Distinguishing between these types is clinically important, as it directly influences management decisions. A dermatologist will typically assess the pattern, distribution, and scalp appearance to determine which form is present, often supported by a scalp biopsy.
Diagnosing Lupus-Related Hair Loss in the UK
Diagnosis involves clinical history, dermoscopy, lupus-specific blood tests, and scalp biopsy; prompt dermatology referral is recommended when scarring alopecia is suspected.
Diagnosing hair loss in the context of lupus requires a thorough clinical assessment that considers both the underlying autoimmune condition and the specific characteristics of the hair loss itself. In the UK, patients are typically assessed initially by their GP, who may refer them to a dermatologist, rheumatologist, or both, depending on whether lupus has already been diagnosed. If scarring alopecia is suspected, prompt referral to dermatology is recommended to prevent irreversible follicle loss.
The diagnostic process usually involves:
-
Full clinical history: Including the pattern and duration of hair loss, any recent lupus flares, current medicines, and associated symptoms such as scalp itching, pain, or redness.
-
Scalp examination: A dermatologist may use dermoscopy — a non-invasive magnification technique — to assess follicle density, scarring, and signs of active inflammation.
-
Blood tests: These may include a full blood count, inflammatory markers (ESR, CRP), renal function tests, urinalysis (to check for protein or blood, which may indicate renal involvement in SLE), complement levels (C3 and C4, which are markers of SLE disease activity), thyroid function tests (to exclude concurrent thyroid disease), ferritin levels, and lupus-specific antibodies such as ANA, anti-dsDNA, and anti-Ro/La.
-
Fungal investigations: Where scaly or inflamed patches are present, fungal scrapings or culture may be taken to exclude tinea capitis before attributing changes to lupus.
-
Scalp biopsy: Particularly important when scarring alopecia is suspected, a small skin sample can confirm the presence of interface dermatitis or follicular destruction consistent with discoid lupus.
NICE guidance on the assessment and management of SLE (2022) recommends a multidisciplinary approach to lupus management, and hair loss should be discussed as part of a holistic review of disease activity. Accurate diagnosis is essential, as the treatment approach differs significantly between scarring and non-scarring forms.
Treatment Options Available on the NHS
Hydroxychloroquine is the first-line NHS treatment for lupus-related hair loss; corticosteroids and immunosuppressants are used for more severe disease, with important pregnancy safety considerations.
Treatment of lupus-related hair loss on the NHS is guided by the underlying cause and the type of alopecia present. The primary goal is to control systemic or cutaneous lupus disease activity, which in turn reduces the inflammatory damage driving hair loss.
Systemic treatments commonly prescribed include:
-
Hydroxychloroquine: A cornerstone of lupus management, this antimalarial medicine reduces immune system overactivity and is effective in managing both SLE and cutaneous lupus, including DLE. It is often the first-line treatment for lupus-related hair loss and is available on NHS prescription. All patients starting hydroxychloroquine should receive baseline counselling about retinal toxicity and be enrolled in regular eye monitoring in line with Royal College of Ophthalmologists recommendations. Hydroxychloroquine is generally considered safe to continue during pregnancy; however, family planning should always be discussed with your specialist.
-
Corticosteroids: Short courses of oral prednisolone or topical corticosteroid preparations (creams, lotions, or intralesional injections) may be used to suppress acute inflammation during flares.
-
Immunosuppressants: Agents such as methotrexate, mycophenolate mofetil, or azathioprine may be introduced for more severe or refractory disease under specialist supervision. Cyclophosphamide may be used for severe, organ-threatening SLE, though it is not used for cutaneous disease alone and is a recognised cause of significant hair loss. Important: Methotrexate and mycophenolate mofetil are teratogenic and must not be taken during pregnancy. Effective contraception is required while taking these medicines, and pregnancy planning must be discussed with your specialist well in advance.
Topical treatments for the scalp may include high-potency corticosteroid lotions or foams applied directly to affected areas, particularly in DLE. Topical tacrolimus (an immunomodulator) is sometimes used off-label for facial or scalp lesions under specialist supervision; patients should be made aware of its off-label status.
For non-scarring hair loss, once disease activity is controlled, regrowth often occurs naturally. In cases of telogen effluvium, no specific hair-directed treatment is usually required beyond managing the underlying condition. Topical minoxidil is UK-licensed for androgenetic alopecia; its use for other forms of non-scarring alopecia is off-label and should be discussed with a specialist.
Smoking is known to worsen cutaneous lupus and may reduce the effectiveness of antimalarial medicines. Smoking cessation is therefore strongly recommended as part of overall lupus management and can be supported through NHS Stop Smoking services.
If you believe a medicine is causing or worsening hair loss, please discuss this with your care team and consider reporting it via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).
Managing Hair Loss and Supporting Regrowth
Gentle hair care, broad-spectrum SPF 50+ sun protection, and correcting confirmed nutritional deficiencies support regrowth; NHS wigs and psychological support are also available.
Alongside medical treatment, there are several practical strategies that can help manage the impact of lupus-related hair loss and support the best possible conditions for regrowth. These measures are particularly relevant during and after lupus flares, when hair is most vulnerable.
Gentle hair care practices are strongly advised:
-
Use mild, sulphate-free shampoos and avoid harsh chemical treatments such as bleaching, perming, or relaxing.
-
Minimise heat styling and allow hair to dry naturally where possible.
-
Avoid tight hairstyles (such as tight ponytails or braids) that place mechanical stress on fragile hair.
-
Use a wide-toothed comb and handle hair gently, especially when wet.
Sun protection is particularly important for people with lupus, as ultraviolet (UV) light is a well-recognised trigger for disease flares and can worsen cutaneous lupus on the scalp. Use a broad-spectrum SPF 50+ sunscreen with a high UVA rating (4 or 5 stars) on exposed scalp areas such as partings, and wear a wide-brimmed hat when outdoors.
Nutritional support may play a role where deficiencies are confirmed. Low levels of iron, vitamin D, and other nutrients have been associated with hair loss more broadly, and blood tests can identify any deficiencies that warrant correction. However, supplementation should only be undertaken to address a confirmed deficiency and on the advice of a healthcare professional — high-dose supplements are not recommended without medical guidance. In particular, biotin (vitamin B7) supplements can interfere with a range of laboratory tests, including thyroid function and cardiac troponin assays, potentially producing misleading results. If you take biotin supplements, inform your care team and consider pausing them before blood tests, in line with MHRA advice.
Practical support: Eligible patients may be able to access wigs or hairpieces through the NHS. Your GP or specialist can advise on referral and eligibility.
Psychological support should not be overlooked. Hair loss can significantly affect self-esteem and mental wellbeing. NHS talking therapies and referral to support organisations such as Lupus UK (www.lupusuk.org.uk) can provide valuable emotional and practical support.
When to Seek Further Medical Advice
Seek prompt review if you notice sudden increased shedding, new bald patches with scalp changes, persistent scalp symptoms, or signs of infection, as early treatment prevents irreversible scarring.
Knowing when to seek further medical advice is an important aspect of managing lupus and its associated hair loss. Whilst some degree of hair shedding during a flare may be expected, certain signs warrant prompt review by a GP or specialist.
Contact your GP or lupus care team if you notice:
-
A sudden or significant increase in hair shedding, particularly if accompanied by other symptoms of a lupus flare (such as joint pain, fatigue, rash, or fever).
-
New bald patches on the scalp, especially if the skin appears red, scaly, or atrophic — this may suggest active discoid lupus requiring urgent treatment to prevent permanent scarring.
-
Scalp symptoms such as persistent itching, burning, tenderness, or pain, which may indicate active cutaneous inflammation.
-
Signs of possible scalp infection, such as painful pustules, oozing, crusting, or rapidly spreading scale — these may indicate a bacterial infection or tinea capitis (ringworm) requiring specific treatment.
-
Hair loss that continues or worsens despite treatment, or that does not improve after a flare has resolved.
-
Concerns about a medicine side effect contributing to hair thinning — this can also be reported via the MHRA Yellow Card scheme.
-
If you are pregnant or planning a pregnancy, discuss this with your care team as soon as possible, as some lupus medicines are not safe during pregnancy and adjustments may be needed.
Early intervention is particularly critical in scarring alopecia, where delays in treatment can result in irreversible follicle loss. If you are already under the care of a rheumatologist or dermatologist, raise hair loss concerns at your next appointment or contact the team's advice line if symptoms are worsening between reviews.
Lupus UK (www.lupusuk.org.uk) is a valuable resource for patients seeking further information, peer support, and guidance on navigating NHS services. Your care team can also refer you to a specialist nurse or a multidisciplinary lupus clinic if your symptoms require more comprehensive management.
Frequently Asked Questions
Can hair grow back after lupus-related hair loss?
In non-scarring forms such as telogen effluvium and lupus hair fringe, regrowth is often possible once disease activity is controlled. However, scarring alopecia caused by discoid lupus erythematosus results in permanent follicle loss, making early diagnosis and treatment essential.
Which lupus medicines are most likely to cause hair loss?
Cyclophosphamide is the most well-recognised cause of significant hair loss in lupus treatment, and methotrexate can also contribute to hair thinning. By contrast, hydroxychloroquine and corticosteroids rarely cause alopecia and often help reduce the inflammation driving hair loss.
When should I see a doctor about hair loss related to lupus?
You should contact your GP or lupus care team promptly if you notice sudden increased shedding, new bald patches with red or atrophic scalp skin, persistent scalp itching or pain, or signs of infection. Early intervention is critical in scarring alopecia to prevent irreversible follicle loss.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
